$2.63 Billion is the total value of Tekla Capital Management LLC's 222 reported holdings in Q2 2020. The portfolio turnover from Q1 2020 to Q2 2020 was 7.8% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| AMGN | Buy | Amgen Inc. | $144,337,000 | +18.7% | 611,962 | +2.0% | 5.49% | -0.1% |
| VRTX | Sell | Vertex Pharmaceuticals Inc. | $138,574,000 | +19.9% | 477,330 | -1.7% | 5.27% | +0.9% |
| GILD | Sell | Gilead Sciences, Inc. | $121,644,000 | -13.8% | 1,581,026 | -16.3% | 4.63% | -27.5% |
| REGN | Buy | Regeneron Pharmaceuticals, Inc. | $117,206,000 | +40.5% | 187,935 | +10.0% | 4.46% | +18.3% |
| JNJ | Sell | Johnson & Johnson | $116,727,000 | +6.1% | 830,031 | -1.0% | 4.44% | -10.6% |
| UNH | Buy | Unitedhealth Group Inc. | $82,631,000 | +46.1% | 280,151 | +23.5% | 3.14% | +23.0% |
| ILMN | Sell | Illumina, Inc. | $79,496,000 | +9.7% | 214,651 | -19.1% | 3.03% | -7.6% |
| MRK | Sell | Merck & Co., Inc. | $75,126,000 | -4.5% | 971,496 | -5.0% | 2.86% | -19.6% |
| BIIB | Sell | Biogen Inc. | $62,499,000 | -40.6% | 233,599 | -29.8% | 2.38% | -50.0% |
| BMY | Buy | Bristol-Myers Squibb Co. | $57,477,000 | +22.0% | 977,505 | +15.7% | 2.19% | +2.8% |
| PFE | Sell | Pfizer Inc. | $54,169,000 | -8.8% | 1,656,548 | -9.0% | 2.06% | -23.2% |
| ABBV | Buy | AbbVie Inc. | $52,401,000 | +101.7% | 533,725 | +56.6% | 1.99% | +69.8% |
| CVS | Buy | CVS Health Corp. | $46,754,000 | +58.2% | 719,620 | +44.5% | 1.78% | +33.2% |
| ABT | Buy | Abbott Laboratories | $44,458,000 | +20.8% | 486,250 | +4.2% | 1.69% | +1.7% |
| MDT | Buy | Medtronic plcshares | $43,602,000 | +8.2% | 475,489 | +6.4% | 1.66% | -8.9% |
| ALXN | Sell | Alexion Pharmaceuticals, Inc. | $43,180,000 | +16.3% | 384,709 | -6.9% | 1.64% | -2.1% |
| SGEN | Buy | Seattle Genetics, Inc. | $40,876,000 | +65.1% | 240,559 | +12.1% | 1.56% | +39.1% |
| TMO | Sell | Thermo Fisher Scientific Inc. | $38,417,000 | +20.9% | 106,025 | -5.4% | 1.46% | +1.8% |
| LLY | Sell | Eli Lilly and Co. | $33,958,000 | -5.4% | 206,837 | -20.0% | 1.29% | -20.3% |
| INCY | Sell | Incyte Corp. | $33,796,000 | +6.8% | 325,053 | -24.8% | 1.29% | -10.1% |
| MRNA | Buy | Moderna, Inc. | $31,624,000 | +315.4% | 492,506 | +93.8% | 1.20% | +250.0% |
| BMRN | Sell | BioMarin Pharmaceutical Inc. | $30,263,000 | +32.3% | 245,362 | -9.3% | 1.15% | +11.4% |
| SYK | Buy | Stryker Corp. | $29,593,000 | +30.9% | 164,230 | +20.9% | 1.13% | +10.2% |
| DHR | Danaher Corp. | $28,178,000 | +27.8% | 159,352 | 0.0% | 1.07% | +7.5% | |
| NBIX | Neurocrine Biosciences, Inc. | $25,150,000 | +41.0% | 206,150 | 0.0% | 0.96% | +18.6% | |
| HZNP | Buy | Horizon Therapeutics plcshares | $22,796,000 | +92.8% | 410,153 | +2.7% | 0.87% | +62.2% |
| BSX | Buy | Boston Scientific Corp. | $22,644,000 | +18.1% | 644,935 | +9.7% | 0.86% | -0.6% |
| SRPT | Sarepta Therapeutics, Inc. | $22,468,000 | +63.9% | 140,129 | 0.0% | 0.86% | +37.9% | |
| EXEL | Buy | Exelixis, Inc. | $22,172,000 | +150.0% | 933,949 | +81.3% | 0.84% | +110.5% |
| ISRG | Sell | Intuitive Surgical, Inc. | $18,998,000 | +12.7% | 33,339 | -2.1% | 0.72% | -5.1% |
| HUM | Buy | Humana Inc. | $18,808,000 | +29.8% | 48,506 | +5.2% | 0.72% | +9.3% |
| ALNY | Sell | Alnylam Pharmaceuticals, Inc. | $18,642,000 | +24.4% | 125,867 | -8.5% | 0.71% | +4.9% |
| BDX | Becton, Dickinson and Co. | $18,604,000 | +4.1% | 77,754 | 0.0% | 0.71% | -12.4% | |
| CNC | Centene Corp. | $18,315,000 | +7.0% | 288,194 | 0.0% | 0.70% | -9.9% | |
| IMMU | Buy | Immunomedics, Inc. | $17,617,000 | +168.3% | 497,103 | +2.1% | 0.67% | +125.9% |
| SNY | Sanofisponsored adr | $16,712,000 | +16.8% | 327,367 | 0.0% | 0.64% | -1.7% | |
| MCK | Buy | McKesson Corp. | $16,498,000 | +104.9% | 107,537 | +80.7% | 0.63% | +72.5% |
| MYL | Mylan N.V.shares | $16,253,000 | +7.9% | 1,010,754 | 0.0% | 0.62% | -9.1% | |
| CI | Sell | Cigna Corp. | $15,010,000 | -40.6% | 79,988 | -43.9% | 0.57% | -50.0% |
| NVS | Sell | Novartis AGsponsored adr | $14,936,000 | +0.7% | 171,008 | -4.9% | 0.57% | -15.2% |
| BGNE | BeiGene, Ltd.sponsored adr | $14,127,000 | +53.0% | 74,984 | 0.0% | 0.54% | +29.0% | |
| EW | Buy | Edwards Lifesciences Corp. | $13,970,000 | +9.9% | 202,146 | +200.0% | 0.53% | -7.5% |
| PRAH | PRA Health Sciences, Inc. | $13,962,000 | +17.2% | 143,508 | 0.0% | 0.53% | -1.5% | |
| TECH | Sell | Bio-Techne Corp. | $13,655,000 | +24.8% | 51,710 | -10.4% | 0.52% | +5.1% |
| AZN | Sell | AstraZeneca PLCsponsored adr | $12,418,000 | +0.7% | 234,798 | -15.0% | 0.47% | -15.1% |
| IDXX | Sell | IDEXX Laboratories, Inc. | $12,221,000 | +25.1% | 37,014 | -8.2% | 0.46% | +5.4% |
| ACAD | Buy | ACADIA Pharmaceuticals Inc. | $12,154,000 | +29.8% | 250,743 | +13.2% | 0.46% | +9.5% |
| IQV | IQVIA Holdings Inc. | $11,672,000 | +31.5% | 82,266 | 0.0% | 0.44% | +10.7% | |
| IONS | Ionis Pharmaceuticals, Inc. | $11,391,000 | +24.7% | 193,201 | 0.0% | 0.43% | +5.1% | |
| ZBH | Buy | Zimmer Biomet Holdings, Inc. | $11,298,000 | +43.0% | 94,653 | +21.1% | 0.43% | +20.4% |
| ZTS | Sell | Zoetis Inc.class a | $11,117,000 | -37.8% | 81,121 | -46.6% | 0.42% | -47.6% |
| ANTM | Sell | Anthem, Inc. | $10,583,000 | -28.9% | 40,242 | -38.6% | 0.40% | -40.1% |
| BAX | Buy | Baxter International Inc. | $10,506,000 | +33.2% | 122,023 | +25.6% | 0.40% | +12.0% |
| WELL | Welltower Inc. | $10,510,000 | +13.0% | 203,083 | 0.0% | 0.40% | -4.8% | |
| ARGX | argenx SEsponsored adr | $10,130,000 | +71.0% | 44,977 | 0.0% | 0.39% | +44.0% | |
| AGIO | Agios Pharmaceuticals, Inc. | $9,999,000 | +50.7% | 186,964 | 0.0% | 0.38% | +27.0% | |
| TEVA | Teva Pharmaceutical Industries Ltd.sponsored adr | $9,690,000 | +37.3% | 785,851 | 0.0% | 0.37% | +15.7% | |
| ALLO | Sell | Allogene Therapeutics, Inc. | $9,252,000 | +94.9% | 216,069 | -11.5% | 0.35% | +63.7% |
| BPMC | Sell | Blueprint Medicines Corp. | $9,224,000 | +13.2% | 118,256 | -15.1% | 0.35% | -4.6% |
| OHI | Omega Healthcare Investors, Inc. | $9,110,000 | +12.0% | 306,433 | 0.0% | 0.35% | -5.7% | |
| MRTX | Mirati Therapeutics, Inc. | $8,995,000 | +48.5% | 78,784 | 0.0% | 0.34% | +24.8% | |
| GSK | Buy | GlaxoSmithKline PLCshares | $8,985,000 | +14.6% | 220,263 | +6.5% | 0.34% | -3.4% |
| NVO | Novo Nordisk A/Ssponsored adr | $8,775,000 | +8.8% | 134,005 | 0.0% | 0.33% | -8.5% | |
| DOC | Physicians Realty Trust | $8,685,000 | +25.7% | 495,733 | 0.0% | 0.33% | +6.1% | |
| ASND | Sell | Ascendis Pharma A/Ssponsored adr | $8,502,000 | +8.9% | 57,482 | -17.1% | 0.32% | -8.2% |
| HCA | HCA Healthcare, Inc. | $8,137,000 | +8.0% | 83,833 | 0.0% | 0.31% | -8.8% | |
| ABC | Buy | AmerisourceBergen Corp. | $8,127,000 | +69.7% | 80,645 | +49.0% | 0.31% | +43.1% |
| RETA | Buy | Reata Pharmaceuticals, Inc.class a | $7,943,000 | +56.6% | 50,907 | +44.9% | 0.30% | +31.9% |
| FGEN | FibroGen, Inc. | $7,874,000 | +16.6% | 194,270 | 0.0% | 0.30% | -1.6% | |
| LH | Buy | Laboratory Corporation of America Holdingssponsored adr | $7,849,000 | +97.6% | 47,251 | +50.4% | 0.30% | +66.1% |
| NVCR | Buy | NovoCure Ltd.ordinary shares | $7,806,000 | +7.9% | 131,637 | +22.5% | 0.30% | -9.2% |
| MPW | Medical Properties Trust, Inc. | $7,741,000 | +8.7% | 411,743 | 0.0% | 0.30% | -8.4% | |
| UTHR | United Therapeutics Corp.class b | $7,685,000 | +27.6% | 63,513 | 0.0% | 0.29% | +7.4% | |
| VTR | Ventas, Inc. | $7,621,000 | +36.7% | 208,108 | 0.0% | 0.29% | +15.1% | |
| RARE | Ultragenyx Pharmaceutical Inc. | $7,625,000 | +76.1% | 97,480 | 0.0% | 0.29% | +48.0% | |
| BCEL | Atreca, Inc. | $7,500,000 | +28.6% | 352,424 | 0.0% | 0.28% | +8.0% | |
| JAZZ | Jazz Pharmaceuticals plcshares | $7,443,000 | +10.6% | 67,456 | 0.0% | 0.28% | -6.9% | |
| GRTX | Buy | Galera Therapeutics, Inc. | $7,439,000 | +87.9% | 1,041,845 | +150.0% | 0.28% | +58.1% |
| IOVA | Buy | Iovance Biotherapeutics, Inc. | $7,441,000 | +12.4% | 271,073 | +22.6% | 0.28% | -5.4% |
| SBRA | Sabra Health Care REIT, Inc. | $7,369,000 | +32.2% | 510,660 | 0.0% | 0.28% | +11.1% | |
| XRAY | Buy | DENTSPLY SIRONA Inc. | $7,106,000 | +59.5% | 161,287 | +40.6% | 0.27% | +34.3% |
| LTC | LTC Properties, Inc. | $6,867,000 | +21.9% | 182,293 | 0.0% | 0.26% | +2.4% | |
| WAT | Buy | Waters Corporation | $6,708,000 | +41.7% | 37,184 | +43.0% | 0.26% | +19.2% |
| GH | Buy | Guardant Health, Inc. | $6,606,000 | +301.3% | 81,422 | +244.2% | 0.25% | +239.2% |
| FATE | Buy | Fate Therapeutics, Inc. | $6,370,000 | +73.1% | 185,672 | +12.1% | 0.24% | +45.8% |
| SYNH | Syneos Health, Inc.class a | $6,291,000 | +47.8% | 108,001 | 0.0% | 0.24% | +24.5% | |
| TFX | Teleflex Inc. | $6,279,000 | +24.3% | 17,252 | 0.0% | 0.24% | +4.8% | |
| PTCT | PTC Therapeutics, Inc. | $6,131,000 | +13.7% | 120,827 | 0.0% | 0.23% | -4.5% | |
| NKTR | Nektar Therapeutics | $6,093,000 | +29.7% | 263,079 | 0.0% | 0.23% | +9.4% | |
| RCKT | Buy | Rocket Pharmaceuticals, Inc. | $6,049,000 | +108.9% | 289,029 | +39.3% | 0.23% | +75.6% |
| AMRN | Buy | Amarin Corporation plcsponsored adr | $5,879,000 | +143.4% | 849,588 | +40.7% | 0.22% | +105.5% |
| ZGNX | Zogenix, Inc. | $5,818,000 | +9.2% | 215,406 | 0.0% | 0.22% | -8.3% | |
| APLS | Apellis Pharmaceuticals, Inc. | $5,666,000 | +21.9% | 173,494 | 0.0% | 0.22% | +2.9% | |
| CRSP | CRISPR Therapeutics AGnamen akt | $5,602,000 | +73.3% | 76,222 | 0.0% | 0.21% | +45.9% | |
| CERN | Cerner Corp. | $5,587,000 | +8.8% | 81,500 | 0.0% | 0.21% | -8.2% | |
| ARNA | Buy | Arena Pharmaceuticals, Inc. | $5,540,000 | +371.1% | 88,002 | +214.3% | 0.21% | +298.1% |
| INO | New | Inovio Pharmaceuticals, Inc. | $5,445,000 | – | 202,038 | +100.0% | 0.21% | – |
| BMYRT | Bristol-Myers Squibb Co.right | $5,276,000 | -5.8% | 1,473,710 | 0.0% | 0.20% | -20.6% | |
| BLUE | bluebird bio, Inc. | $5,139,000 | +32.8% | 84,194 | 0.0% | 0.20% | +12.0% | |
| FOLD | Sell | Amicus Therapeutics, Inc. | $5,082,000 | +49.1% | 336,984 | -8.7% | 0.19% | +25.3% |
| STRO | Sutro Biopharma, Inc. | $4,976,000 | -23.9% | 641,268 | 0.0% | 0.19% | -36.1% | |
| MTD | Mettler-Toledo International Inc. | $4,932,000 | +16.7% | 6,123 | 0.0% | 0.19% | -1.6% | |
| MOH | New | Molina Healthcare, Inc. | $4,901,000 | – | 27,536 | +100.0% | 0.19% | – |
| XNCR | Xencor, Inc. | $4,801,000 | +8.4% | 148,231 | 0.0% | 0.18% | -8.5% | |
| TBPH | Theravance Biopharma, Inc. | $4,803,000 | -9.2% | 228,836 | 0.0% | 0.18% | -23.4% | |
| A | Agilent Technologies, Inc. | $4,642,000 | +23.4% | 52,525 | 0.0% | 0.18% | +4.1% | |
| ALLK | Allakos Inc. | $4,628,000 | +61.5% | 64,397 | 0.0% | 0.18% | +35.4% | |
| GBT | Sell | Global Blood Therapeutics, Inc. | $4,530,000 | -24.9% | 71,759 | -39.2% | 0.17% | -37.0% |
| PIRS | Pieris Pharmaceuticals, Inc. | $4,493,000 | +36.0% | 1,449,269 | 0.0% | 0.17% | +14.8% | |
| ARDX | Ardelyx, Inc. | $4,205,000 | +21.7% | 607,698 | 0.0% | 0.16% | +2.6% | |
| PEAK | Healthpeak Properties, Inc. | $4,145,000 | +15.6% | 150,392 | 0.0% | 0.16% | -2.5% | |
| SAGE | Sage Therapeutics Inc | $4,000,000 | +44.8% | 96,211 | 0.0% | 0.15% | +21.6% | |
| XLRN | Acceleron Pharma Inc. | $3,869,000 | +6.0% | 40,606 | 0.0% | 0.15% | -10.9% | |
| EDIT | Editas Medicine, Inc. | $3,851,000 | +49.1% | 130,201 | 0.0% | 0.15% | +25.6% | |
| AMED | New | Amedisys, Inc. | $3,851,000 | – | 19,395 | +100.0% | 0.15% | – |
| EXAS | Buy | Exact Sciences Corp. | $3,827,000 | +185.2% | 44,015 | +90.3% | 0.15% | +139.3% |
| ABMD | Sell | ABIOMED, Inc. | $3,815,000 | -11.0% | 15,794 | -46.5% | 0.14% | -25.3% |
| SNN | Smith & Nephew plcshares | $3,795,000 | +6.3% | 99,560 | 0.0% | 0.14% | -10.6% | |
| PKI | PerkinElmer, Inc. | $3,776,000 | +30.3% | 38,494 | 0.0% | 0.14% | +9.9% | |
| TAK | Takeda Pharmaceutical Company Ltd.sponsored ads | $3,768,000 | +18.1% | 210,146 | 0.0% | 0.14% | -0.7% | |
| MNTA | Buy | Momenta Pharmaceuticals, Inc. | $3,719,000 | +49.7% | 111,768 | +22.4% | 0.14% | +26.8% |
| ICPT | Buy | Intercept Pharmaceuticals, Inc. | $3,692,000 | +70.4% | 77,067 | +123.9% | 0.14% | +43.9% |
| DCPH | Deciphera Pharmaceuticals, Inc. | $3,665,000 | +45.0% | 61,370 | 0.0% | 0.14% | +21.9% | |
| Trillium Therapeutics Inc. | $3,625,000 | +100.3% | 448,049 | 0.0% | 0.14% | +68.3% | ||
| CHRS | Buy | Coherus Biosciences, Inc. | $3,627,000 | +100.3% | 203,103 | +81.9% | 0.14% | +68.3% |
| PRNB | New | Principia Biopharma Inc. | $3,611,000 | – | 60,390 | +100.0% | 0.14% | – |
| LGND | Ligand Pharmaceuticals Inc. | $3,421,000 | +53.8% | 30,590 | 0.0% | 0.13% | +28.7% | |
| RMD | ResMed Inc. | $3,424,000 | +30.4% | 17,831 | 0.0% | 0.13% | +9.2% | |
| EPZM | Epizyme, Inc. | $3,336,000 | +3.5% | 207,752 | 0.0% | 0.13% | -13.0% | |
| KRTX | New | Karuna Therapeutics, Inc. | $3,330,000 | – | 29,873 | +100.0% | 0.13% | – |
| YMAB | Y-mAbs Therapeutics, Inc. | $3,307,000 | +65.5% | 76,548 | 0.0% | 0.13% | +40.0% | |
| ALKS | Alkermes plcshares | $3,297,000 | +34.6% | 169,930 | 0.0% | 0.12% | +12.6% | |
| ACHC | Acadia Healthcare Company, Inc. | $3,296,000 | +36.9% | 131,200 | 0.0% | 0.12% | +14.7% | |
| CRL | Charles River Laboratories International, Inc. | $3,220,000 | +38.1% | 18,467 | 0.0% | 0.12% | +17.1% | |
| ARWR | Arrowhead Pharmaceuticals, Inc. | $3,204,000 | +50.1% | 74,186 | 0.0% | 0.12% | +27.1% | |
| CRBP | New | Corbus Pharmaceuticals Holdings, Inc. | $3,177,000 | – | 378,706 | +100.0% | 0.12% | – |
| GWPH | Sell | GW Pharmaceuticals plcads | $3,074,000 | -29.9% | 25,051 | -50.0% | 0.12% | -40.9% |
| ZLAB | Zai Lab Ltd.adr | $3,082,000 | +59.5% | 37,523 | 0.0% | 0.12% | +34.5% | |
| HR | Healthcare Realty Trust Inc. | $3,047,000 | +4.9% | 104,024 | 0.0% | 0.12% | -11.5% | |
| QTNT | Buy | Quotient Ltd. | $3,048,000 | +196.8% | 411,937 | +58.4% | 0.12% | +152.2% |
| DXCM | New | DexCom, Inc. | $2,940,000 | – | 7,251 | +100.0% | 0.11% | – |
| PRGO | Buy | Perrigo Company plcshares | $2,831,000 | +444.4% | 51,224 | +373.5% | 0.11% | +350.0% |
| QURE | Buy | uniQure N.V.shares | $2,841,000 | +36.5% | 63,039 | +43.8% | 0.11% | +14.9% |
| OVID | Ovid Therapeutics Inc.sponsored adr | $2,747,000 | +147.3% | 372,733 | 0.0% | 0.10% | +110.0% | |
| ALGN | Align Technology, Inc. | $2,756,000 | +57.8% | 10,041 | 0.0% | 0.10% | +32.9% | |
| INSM | Insmed Inc. | $2,710,000 | +71.8% | 98,387 | 0.0% | 0.10% | +45.1% | |
| ANAB | AnaptysBio, Inc. | $2,642,000 | +58.1% | 118,261 | 0.0% | 0.10% | +32.9% | |
| AXSM | Axsome Therapeutics, Inc. | $2,599,000 | +39.9% | 31,591 | 0.0% | 0.10% | +17.9% | |
| PHG | Koninklijke Philips N.V.ny reg sh | $2,613,000 | +16.6% | 55,796 | 0.0% | 0.10% | -2.0% | |
| BHVN | Sell | Biohaven Pharmaceutical Holding Company Ltd. | $2,506,000 | +63.0% | 34,277 | -24.1% | 0.10% | +37.7% |
| AVRO | Buy | AVROBIO, Inc. | $2,453,000 | +110.6% | 140,581 | +87.8% | 0.09% | +75.5% |
| ITCI | Intra-Cellular Therapies, Inc. | $2,419,000 | +67.1% | 94,238 | 0.0% | 0.09% | +41.5% | |
| DGX | Quest Diagnostics Inc. | $2,396,000 | +41.9% | 21,025 | 0.0% | 0.09% | +19.7% | |
| NVAX | Novavax, Inc. | $2,380,000 | +513.4% | 28,550 | 0.0% | 0.09% | +405.6% | |
| BHC | Bausch Health Companies Inc. | $2,166,000 | +18.0% | 118,412 | 0.0% | 0.08% | -1.2% | |
| ESPR | Esperion Therapeutics, Inc. | $2,133,000 | +62.7% | 41,577 | 0.0% | 0.08% | +37.3% | |
| ALC | Alcon Inc.ordinary shares | $2,103,000 | +12.8% | 36,686 | 0.0% | 0.08% | -4.8% | |
| RVNC | Revance Therapeutics, Inc. | $2,096,000 | +65.0% | 85,840 | 0.0% | 0.08% | +40.4% | |
| ZYME | Buy | Zymeworks Inc. | $2,018,000 | +274.4% | 55,938 | +268.2% | 0.08% | +220.8% |
| PTLA | Portola Pharmaceuticals, Inc.sponsored adr | $1,965,000 | +152.2% | 109,246 | 0.0% | 0.08% | +114.3% | |
| GMRE | Global Medical REIT Inc. | $1,982,000 | +12.0% | 174,897 | 0.0% | 0.08% | -6.2% | |
| CLLS | Cellectissponsored adr | $1,961,000 | +93.6% | 110,147 | 0.0% | 0.08% | +63.0% | |
| HRTX | Heron Therapeutics, Inc. | $1,930,000 | +25.3% | 131,183 | 0.0% | 0.07% | +4.3% | |
| AVDL | Sell | Avadel Pharmaceuticals plcsponsored adr | $1,888,000 | -58.0% | 233,612 | -58.7% | 0.07% | -64.5% |
| HALO | Halozyme Therapeutics, Inc. | $1,874,000 | +49.0% | 69,917 | 0.0% | 0.07% | +24.6% | |
| MYOK | MyoKardia, Inc. | $1,865,000 | +106.1% | 19,300 | 0.0% | 0.07% | +73.2% | |
| HTA | Healthcare Trust of America, Inc. | $1,874,000 | +9.2% | 70,662 | 0.0% | 0.07% | -9.0% | |
| HOLX | Hologic, Inc. | $1,856,000 | +62.4% | 32,564 | 0.0% | 0.07% | +36.5% | |
| ENDP | Endo International plcshares | $1,823,000 | -7.3% | 531,570 | 0.0% | 0.07% | -22.5% | |
| INGN | Inogen, Inc. | $1,826,000 | -31.2% | 51,406 | 0.0% | 0.07% | -42.5% | |
| MEDP | Medpace Holdings, Inc. | $1,755,000 | +26.7% | 18,871 | 0.0% | 0.07% | +6.3% | |
| THC | Tenet Healthcare Corp. | $1,752,000 | +25.8% | 96,736 | 0.0% | 0.07% | +6.3% | |
| STE | STERIS plcshares | $1,721,000 | +9.6% | 11,218 | 0.0% | 0.07% | -7.0% | |
| PACB | Pacific Biosciences of California, Inc. | $1,709,000 | +12.7% | 495,495 | 0.0% | 0.06% | -5.8% | |
| EVH | Evolent Health, Inc. | $1,645,000 | +31.2% | 231,027 | 0.0% | 0.06% | +10.5% | |
| DHC | Diversified Healthcare Trust | $1,583,000 | +21.9% | 357,720 | 0.0% | 0.06% | +1.7% | |
| MDGL | Madrigal Pharmaceuticals, Inc. | $1,511,000 | +69.6% | 13,340 | 0.0% | 0.06% | +45.0% | |
| ADUS | New | Addus HomeCare Corp. | $1,478,000 | – | 15,969 | +100.0% | 0.06% | – |
| AUPH | Aurinia Pharmaceuticals Inc. | $1,475,000 | +12.0% | 90,788 | 0.0% | 0.06% | -6.7% | |
| MGTA | Buy | Magenta Therapeutics, Inc. | $1,445,000 | +1276.2% | 192,431 | +1048.4% | 0.06% | +1000.0% |
| ASRT | New | Assertio Holdings, Inc. | $1,407,000 | – | 1,642,302 | +100.0% | 0.05% | – |
| TCDA | New | Tricida, Inc. | $1,384,000 | – | 50,370 | +100.0% | 0.05% | – |
| SGMO | Sangamo Therapeutics, Inc. | $1,343,000 | +40.8% | 149,835 | 0.0% | 0.05% | +18.6% | |
| WVE | WaVe Life Sciences Ltd.shares | $1,334,000 | +11.1% | 128,146 | 0.0% | 0.05% | -5.6% | |
| GLPG | Galapagos NVsponsored adr | $1,291,000 | +0.7% | 6,543 | 0.0% | 0.05% | -15.5% | |
| BBIO | BridgeBio Pharma, Inc. | $1,279,000 | +12.4% | 39,228 | 0.0% | 0.05% | -3.9% | |
| KOD | Kodiak Sciences Inc. | $1,253,000 | +13.5% | 23,153 | 0.0% | 0.05% | -4.0% | |
| VRNA | Verona Pharma plcsponsored adr | $1,182,000 | +13.3% | 253,179 | 0.0% | 0.04% | -4.3% | |
| ACIU | AC Immune SAshares | $1,156,000 | -2.6% | 171,813 | 0.0% | 0.04% | -18.5% | |
| NTLA | Intellia Therapeutics, Inc. | $1,157,000 | +71.9% | 55,050 | 0.0% | 0.04% | +46.7% | |
| XLV | Health Care Select Sector SPDR Fundsbi healthcare | $1,006,000 | +12.9% | 10,055 | 0.0% | 0.04% | -5.0% | |
| AXNX | Axonics Modulation Technologies, Inc. | $987,000 | +38.2% | 28,100 | 0.0% | 0.04% | +18.8% | |
| AERI | Aerie Pharmaceuticals, Inc. | $984,000 | +9.3% | 66,688 | 0.0% | 0.04% | -9.8% | |
| RUBY | Rubius Therapeutics, Inc. | $933,000 | +34.4% | 155,982 | 0.0% | 0.04% | +16.1% | |
| MNLO | Buy | Menlo Therapeutics Inc. | $937,000 | +96.0% | 541,584 | +204.0% | 0.04% | +63.6% |
| EIDX | Eidos Therapeutics, Inc. | $953,000 | -2.8% | 20,000 | 0.0% | 0.04% | -18.2% | |
| SNR | New Senior Investment Group Inc. | $928,000 | +41.5% | 256,398 | 0.0% | 0.04% | +16.7% | |
| UHT | Universal Health Realty Income Trustshares | $895,000 | -21.1% | 11,258 | 0.0% | 0.03% | -33.3% | |
| GRFS | Grifols, S.A.sponsored adr | $864,000 | -9.4% | 47,373 | 0.0% | 0.03% | -23.3% | |
| New | Innate Pharma SAsponsored ads | $858,000 | – | 137,734 | +100.0% | 0.03% | – | |
| MIST | Milestone Pharmaceuticals Inc. | $806,000 | +105.6% | 213,310 | 0.0% | 0.03% | +72.2% | |
| RGNX | REGENXBIO Inc. | $799,000 | +13.7% | 21,700 | 0.0% | 0.03% | -6.2% | |
| IMGN | ImmunoGen, Inc. | $774,000 | +34.8% | 168,190 | 0.0% | 0.03% | +11.5% | |
| PBYI | Puma Biotechnology, Inc. | $744,000 | +23.6% | 71,340 | 0.0% | 0.03% | +3.7% | |
| CDTX | Cidara Therapeutics, Inc. | $720,000 | +48.8% | 195,256 | 0.0% | 0.03% | +22.7% | |
| CHCT | Community Healthcare Trust Inc. | $609,000 | +6.8% | 14,900 | 0.0% | 0.02% | -11.5% | |
| NHI | National Health Investors, Inc. | $610,000 | +22.7% | 10,038 | 0.0% | 0.02% | +4.5% | |
| MOR | MorphoSys AGsponsored ads | $614,000 | +29.0% | 19,390 | 0.0% | 0.02% | +4.5% | |
| MTEM | Molecular Templates, Inc. | $583,000 | +3.7% | 42,313 | 0.0% | 0.02% | -12.0% | |
| GMAB | Sell | Genmab A/Ssponsored ads | $560,000 | -82.2% | 16,520 | -88.8% | 0.02% | -85.2% |
| SPPI | Spectrum Pharmaceuticals, Inc. | $388,000 | +45.3% | 114,670 | 0.0% | 0.02% | +25.0% | |
| TPTX | Turning Point Therapeutics, Inc. | $367,000 | +44.5% | 5,677 | 0.0% | 0.01% | +27.3% | |
| CYH | Community Health Systems, Inc. | $354,000 | -9.9% | 117,735 | 0.0% | 0.01% | -27.8% | |
| CBAY | CymaBay Therapeutics, Inc. | $307,000 | +136.2% | 88,102 | 0.0% | 0.01% | +100.0% | |
| ARPO | Aerpio Pharmaceuticals, Inc. | $322,000 | +126.8% | 257,554 | 0.0% | 0.01% | +100.0% | |
| CLSD | Clearside Biomedical, Inc. | $311,000 | +10.7% | 165,330 | 0.0% | 0.01% | -7.7% | |
| ABIO | Sell | ARCA biopharma, Inc. | $215,000 | +115.0% | 32,461 | -10.0% | 0.01% | +60.0% |
| FVE | Five Star Senior Living Inc. | $95,000 | +41.8% | 24,237 | 0.0% | 0.00% | +33.3% | |
| TTPH | Tetraphase Pharmaceuticals, Inc. | $108,000 | +96.4% | 42,965 | 0.0% | 0.00% | +100.0% | |
| CLDX | Celldex Therapeutics, Inc. | $92,000 | +666.7% | 7,053 | 0.0% | 0.00% | +300.0% | |
| MNKKQ | Mallinckrodt plcsponsored adr | $88,000 | +35.4% | 32,980 | 0.0% | 0.00% | 0.0% | |
| Bellicum Pharmaceuticals, Inc. | $45,000 | +60.7% | 6,000 | 0.0% | 0.00% | +100.0% | ||
| QHCCQ | Exit | Quorum Health Corporation | $0 | – | -23,725 | -100.0% | 0.00% | – |
| VIE | Exit | Viela Bio, Inc. | $0 | – | -500 | -100.0% | -0.00% | – |
| MRUS | Exit | Merus N.V. | $0 | – | -21,215 | -100.0% | -0.01% | – |
| HQY | Exit | HealthEquity, Inc. | $0 | – | -27,310 | -100.0% | -0.06% | – |
| RARX | Exit | Ra Pharmaceuticals, Inc. | $0 | – | -35,743 | -100.0% | -0.08% | – |
| AGN | Exit | Allergan plcshares | $0 | – | -157,981 | -100.0% | -1.26% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-08-13
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Gilead Sciences, Inc. | 41 | Q2 2023 | 12.4% |
| Amgen, Inc. | 41 | Q2 2023 | 5.8% |
| Biogen Inc. | 41 | Q2 2023 | 6.5% |
| Vertex Pharmaceuticals Incorporated | 41 | Q2 2023 | 5.3% |
| Regeneron Pharmaceuticals, Inc. | 41 | Q2 2023 | 9.1% |
| Illumina, Inc. | 41 | Q2 2023 | 3.4% |
| BioMarin Pharmaceutical Inc. | 41 | Q2 2023 | 2.9% |
| Teva Pharmaceutical Industries Ltd. | 41 | Q2 2023 | 3.2% |
| Neurocrine Biosciences, Inc. | 41 | Q2 2023 | 1.4% |
| McKesson Corporation | 41 | Q2 2023 | 2.2% |
View Tekla Capital Management LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Rallybio Corp | January 23, 2023 | 1,727,067 | 4.6% |
| Zyla Life SciencesSold out | January 29, 2021 | 0 | 0.0% |
| ARCA biopharma, Inc. | January 24, 2020 | 36,068 | 2.3% |
| Verona Pharma plc | February 12, 2019 | 5,296,845 | 4.9% |
| Alliqua BioMedical, Inc. | February 12, 2018 | 165,000 | 3.3% |
| PIERIS PHARMACEUTICALS, INC. | February 12, 2018 | 1,962,380 | 4.4% |
| Intellipharmaceutics International Inc. | February 13, 2015 | 2,184,000 | 9.0% |
| HERON THERAPEUTICS, INC. /DE/ | February 14, 2014 | 20,598,613 | 4.2% |
| MEDWAVE INC | February 14, 2012 | 1,277,372 | 9.8% |
| MZT Holdings, Inc. | February 14, 2012 | 2,553,420 | 4.0% |
View Tekla Capital Management LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2023-08-10 |
| 13F-HR | 2023-05-10 |
| 13F-HR | 2023-02-10 |
| SC 13G/A | 2023-01-23 |
| 13F-HR | 2022-11-01 |
| 13F-HR | 2022-07-29 |
| 13F-HR | 2022-05-13 |
| 13F-HR | 2022-02-14 |
| SC 13G | 2022-01-21 |
| 13F-HR | 2021-11-12 |
View Tekla Capital Management LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.